CPL mitigates myeloproliferative neoplasms through dual targeting of cell senescence and NF-?B signaling
To investigate the therapeutic effect of CPL on myeloproliferative neoplasms. We then performed gene expression profiling using data obtained by RNA-seq in SET-2 cells treated with or without CPL. Overall design: Comparative gene expression profiling of RNA-seq data from SET-2 cells treated and untreated with CPL